Fig. 1: Timeline of treatment initiation and CT-imaging evaluation. | npj Precision Oncology

Fig. 1: Timeline of treatment initiation and CT-imaging evaluation.

From: Osimertinib and palbociclib in an EGFR-mutated NSCLC with primary CDK4 amplification after progression under osimertinib

Fig. 1

The timeline represents the time of starting TKI treatment with osimertinib followed by adding palbociclib to osimertinib (green boxes). CT images have been provided at different timepoints for response evaluation (blue boxes). During treatment a pneumonitis occured (red boxes). The arrowhead represents ongoing response.

Back to article page